ABP 206 (nivolumab biosimilar) - Amgen
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
https://www.reuters.com/legal/litigation/bristol-myers-sues-amgen-over-proposed-opdivo-biosimilar-2026-09-15/
 
Sep 15, 2026
 
Next